Results
75,408 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Cutler David GChief Technology Officer |  EYENational Vision Holdings, Inc.Option exercise | M | — 13.0K sh | Sep 9, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Cutler David GChief Technology Officer | EYENational Vision Holdings, Inc. Option exercise | M | — 13.0K sh | Sep 9, 2026 |
| 21 | Purcell Lynn SebastianDirector, 10% Owner |  CNXUConexeu Sciences Inc.In-the-money exercise | X | $500K 217.6K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair |  TARSTarsus Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $265K 2,900 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 |  Cory A. BookerDSpouse |  ALNYALNYLAM PHARMACEUTICALS, INC.Sale (Full) | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 11, 2026 |
| 20 |  April McClain DelaneyDDependent child |  ESEESCO TECHNOLOGIES INCPurchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 20, 2026 |
| 20 | April McClain DelaneyDDependent child | ESEESCO TECHNOLOGIES INC Purchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 24, 2026 |
| 20 | April McClain DelaneyDDependent child |  MLMMARTIN MARIETTA MATERIALS INCPurchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 19, 2026 |
| 20 | April McClain DelaneyDDependent child |  LHLABCORP HOLDINGS INC.Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 7, 2026 |
| 20 | April McClain DelaneyDDependent child | LHLABCORP HOLDINGS INC. Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 6, 2026 |
| 20 | April McClain DelaneyDDependent child |  TDYTELEDYNE TECHNOLOGIES INCPartial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 19, 2026 |
| 20 | Wassil JimEVP, Chief Scientific Ofc, COO |  PCVXVaxcyte, Inc.Open-market sale | SELL | $79K 1,334 sh | Sep 9, 2026 traded Sep 9, 2026 |
| 20 |  Maria Elvira SalazarRSelf |  MRNAModerna, Inc.Partial sale | SELL | $1,001 – $15K | Sep 9, 2026 traded Aug 19, 2026 |
| 20 | April McClain DelaneyDDependent child | TDYTELEDYNE TECHNOLOGIES INC Sale | SELL | $15K – $50K | Sep 9, 2026 traded Aug 25, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $641K 7,100 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Chen Sean ChihhsiangPresident and COO |  AMBQAmbiq Micro, Inc.Open-market sale · 10b5-1 plan | SELL | $123K 2,126 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Pfeiffer DeborahEVP & Pres, Presort Services |  PBIPITNEY BOWES INC /DE/Open-market sale · 10b5-1 plan | SELL | $342K 20.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 20 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $974K 22.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Mulshine Brendan MartinCo-President and CRO |  RYANRYAN SPECIALTY HOLDINGS, INC.Derivative conversion | C | — 40.0K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Allison SchwartzDirector |  BIOBIO.BBIO-RAD LABORATORIES, INC.Tax withholding | F | $32K 82 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 92 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 19 | Barry JamesEVP, President, LSG | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 1,027 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Yates Daniel S.SVP, Chief Accounting Officer |  DTDynatrace, Inc.Option exercise | M | — 558 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Akgonul Rifat KerimChief Product Officer |  PEGAPEGASYSTEMS INCOption exercise | M | — 2,202 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Yates Daniel S.SVP, Chief Accounting Officer | DTDynatrace, Inc. Option exercise | M | — 718 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 1,027 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | McMahon Stephen AEVP, Chief Customer Officer | DTDynatrace, Inc. Option exercise | M | — 5,821 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Aviles EdithDirector |  SMGSCOTTS MIRACLE-GRO COGrant or award | A | — 118 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Mulshine Brendan MartinCo-President and CRO | RYANRYAN SPECIALTY HOLDINGS, INC. Derivative conversion | C | — 40.0K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 228 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Option exercise | M | $326K 10.8K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 19 | Higgins John GerardChief, Client &Partner Success | PEGAPEGASYSTEMS INC Option exercise | M | — 1,616 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Zugelder DanEVP, Chief Revenue Officer | DTDynatrace, Inc. Option exercise | M | — 3,220 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Scheiwer Mark JEVP, CFO & CAO | SMGSCOTTS MIRACLE-GRO CO Grant or award | A | — 47 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Carr DouglasSVP Finance & Operations |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $521 254 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 19 | Sluis FrankCFO |  ONONOn Holding AGOption exercise | M | — 1,684 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 18 | Leibrock Robert WilliamChief Financial Officer |  ACIWACI WORLDWIDE, INC.Disposition to issuer | D | $101K 1,905 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 18 | Evans AichaDirector |  JOBYJoby Aviation, Inc.Gift | G | — 24.6K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 18 | McMahon Stephen AEVP, Chief Customer Officer | DTDynatrace, Inc. Tax withholding | F | $112K 2,149 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 18 | Zugelder DanEVP, Chief Revenue Officer | DTDynatrace, Inc. Tax withholding | F | $166K 3,201 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 18 | Oliver Robin LeighDirector, COO |  BAFNBayFirst Financial Corp.Other acquisition or disposition | J | $300 48 sh | Sep 9, 2026 traded Sep 4, 2026 |